Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$25,955,329
+$2,770,755 QoQ
Shares Held
201,987
+4.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#460
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Derivatives in MRK
reported options exposure · as of Dec 31, 2025CallValue
$157,890,000
CallShares
1,500,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aptus Capital Advisors, LLC holds $223,621,682 across 14 Drug Manufacturers - General names. MRK ranks #4 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
53,662 | $64,363,817 | |
| 2 | JNJ |
Johnson & Johnson
|
201,691 | $51,223,462 | |
| 3 | ABBV |
AbbVie Inc.
|
142,030 | $35,740,429 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
201,987 | $25,955,329 | |
| 5 | AMGN |
Amgen Inc
|
42,764 | $15,485,699 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
74,929 | $9,466,529 | |
| 7 | PFE |
Pfizer Inc
|
365,411 | $8,799,096 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
134,318 | $7,739,403 |
All Filings in MRK
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,955,329 | 201,987 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $23,184,574 | 192,739 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $21,844,186 | 207,526 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $157,890,000 | 1,500,000 | Call | Sole | 2026-02-13 | |
| 2025-09-30 | $21,296,901 | 253,746 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $20,001,753 | 252,675 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $7,569,370 | 84,329 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $9,090,382 | 91,379 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $16,569,993 | 145,914 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $12,635,275 | 102,062 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $10,863,047 | 82,327 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $109,020,000 | 1,000,000 | Call | Sole | 2024-02-13 | |
| 2023-12-31 | $7,884,435 | 72,321 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $7,575,575 | 73,585 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $8,167,304 | 70,780 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,981,803 | 75,024 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $10,012,128 | 90,240 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,744,487 | 78,315 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $6,845,225 | 75,082 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $3,068,998 | 37,404 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $634,042 | 8,273 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $655,409 | 8,726 | Shares | Sole | 2021-10-27 | |
| 2021-09-30 | $120,176,000 | 1,600,000 | Call | Sole | 2021-10-27 | |
| 2021-06-30 | $3,057,216 | 39,311 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $2,627,767 | 34,087 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $2,791,504 | 34,126 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,852,651 | 34,390 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $563,658 | 7,289 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $571,356 | 7,426 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||